已建立和新兴的氟-18标记心脏PET放射性示踪剂
本文综述氟-18(18F)标记心脏PET放射性示踪剂的优势与临床应用。除常规使用的18F-氟脱氧葡萄糖用于评估心肌存活、心脏结节病及人工瓣膜和心脏装置感染外,18F-flurpiridaz已获美国食品药品监督管理局批准用于心肌灌注显像并可准确定量心肌血流量;18F-氟化钠可检测代谢活跃的心外膜冠状动脉粥样硬化病变;18F标记淀粉样蛋白示踪剂包括氟比他班、氟美他酚和氟贝他苯。综述还探讨应用于心脏结节病、心肌神经支配及持续纤维化/成纤维细胞活化的新兴18F标记探针。
要点
- 18F标记心脏PET示踪剂具有半衰期109.7分钟、单位剂量可用及正电子射程短带来的高空间分辨率优势。
- 18F-氟脱氧葡萄糖常规用于评估心肌存活、心脏结节病以及人工瓣膜和心脏装置感染。
- 18F-flurpiridaz已获美国食品药品监督管理局批准用于心肌灌注显像,并可准确定量心肌血流量。
核心结论
- 18F标记放射性示踪剂在心脏PET成像中具有优势,除18F-氟脱氧葡萄糖外,多种新型18F标记放射性药物已进入临床评估,为评估疾病通路提供新方法。
研究设计与样本
- 综述,检索范围与纳入文献原文未报告。
诊断标准与关键数值
- 18F-flurpiridaz已获美国食品药品监督管理局批准用于心肌灌注显像,并可准确定量心肌血流量。
- 18F-氟化钠用于检测代谢活跃的心外膜冠状动脉粥样硬化病变。
- 18F标记淀粉样蛋白放射性示踪剂包括氟比他班、氟美他酚和氟贝他苯。
临床应用与阅片要点
- 18F-氟脱氧葡萄糖在常规临床实践中用于评估心肌存活、心脏结节病以及人工瓣膜和心脏装置感染。
- 18F-flurpiridaz适用于心肌灌注显像并可准确定量心肌血流量。
- 18F-氟化钠可用于检测代谢活跃的心外膜冠状动脉粥样硬化病变。
- 18F标记淀粉样蛋白放射性示踪剂包括氟比他班、氟美他酚和氟贝他苯,可用于心脏淀粉样蛋白成像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Positron emission tomography (PET)/computed tomography is a major imaging strategy for cardiovascular disease characterization. Whereas multiple radioisotopes can be used for PET imaging of cardiac disease processes, fluorine-18 (18F) presents key advantages. These include availability as a unit dose given a favorable half-life of 109.7 minutes and a short positron range leading to a high spatial resolution. In this context, there is growing interest in the development of novel 18F-labeled probes applied to cardiac PET imaging, which in turn provide clinicians with new methods to evaluate disease pathways of interest. Beyond 18F-fluorodeoxyglucose, used in routine clinical practice to scrutinize myocardial viability, cardiac sarcoidosis, as well as prosthetic valve and cardiac device infection, new 18F-labeled radiopharmaceuticals have undergone clinical evaluation. These include 18F-flurpiridaz, which was recently approved by the U.S. Food and Drug Administration for myocardial perfusion imaging and that is also amenable to accurate myocardial blood flow quantitation, 18F-sodium fluoride to detect metabolically active epicardial coronary atherosclerotic lesions, and the 18F-labeled amyloid radiotracers florbetapir, flutemetamol, and florbetaben. This review will further explore emerging 18F-labeled probes applied to cardiac sarcoidosis, myocardial innervation, and ongoing fibrosis/fibroblast activation.
引用
- Packard RRS, Pelletier-Galarneau M, Malhotra S, et al. Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers. JACC Cardiovasc Imaging. 2025. PMID: 40439626. doi:10.1016/j.jcmg.2025.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。